SNPX - Synaptogenix

-

$undefined

N/A

(N/A)

Synaptogenix NasdaqCM:SNPX Synaptogenix, Inc. operates as a biopharmaceutical company. The company is primarily focused on developing a product platform based upon Bryostatin-1, for the treatment of Alzheimer's disease (AD), which is in the clinical testing stage. It is also evaluating potential therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis (MS), and Niemann-Pick Type C disease, which have undergone pre-clinical testing. The company was incorporated in 2012 and is headquartered in New York, New York.

Location: 1185 Avenue of the Americas, New York, NY, 10036, United States | Website: https://www.synaptogen.com | Industry: Biotechnology | Sector: Healthcare


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

-10.08M

Cash

14.83M

Avg Qtr Burn

-1.263M

Short % of Float

0.31%

Insider Ownership

1.90%

Institutional Own.

3.76%

Qtr Updated

03/31/25